Chemistry Reference
In-Depth Information
67. Wright RS, Anderson JW, and Bridges SR. Propionate inhibits hepatocyte lipid synthe-
sis.
Proc Soc Exp Biol Med.
1990;195(1):26-29.
68. Nishina PM and Freedland RA. Effects of propionate on lipid biosynthesis in isolated rat
hepatocytes.
J Nutr.
1990;120(7):668-673.
69. Hara H, Haga S, Aoyama Y, and Kiriyama S. Short-chain fatty acids suppress choles-
terol synthesis in rat liver and intestine.
J Nutr.
1999;129(5):942-948.
70. Illman RJ and Topping DL. Effects of dietary oat bran on faecel steroid excretion,
plasma volatile fatty acids and lipid synthesis in rats.
Nutr Res.
1985;5:839-846.
71. Ahrens F, Hagemeister H, Pfeuffer M, and Barth CA. Effects of oral and intracecal pec-
tin administration on blood lipids in minipigs.
J Nutr.
1986;116(1):70-76.
72. Illman RJ, Topping DL, McIntosh GH, Trimble RP, Storer GB, Taylor MN, and Cheng
BQ. Hypocholesterolaemic effects of dietary propionate: Studies in whole animals and
perfused rat liver.
Ann Nutr Metab.
1988;32(2):95-107.
73. Dawson AM, Holdsworth CD, and Webb J. Absorption of short chain fatty acids in man.
Proc Soc Exp Biol Med.
1964;117:97-100.
74. Saunders D. Absorption of short chain fatty acids in human stomach and rectum.
Nutr
Res.
1991;11:841-847.
75. In: Cummings JH, Rombeau JL, and Sakata T, eds.
Physiological and Clinical Aspects
of Short-Chain Fatty Acids
. Cambridge University Press, New York, 1995.
76. Dankert J, Zijlstra JB, and Wolthers BG. Volatile fatty acids in human peripheral and
portal blood: Quantitative determination vacuum distillation and gas chromatography.
Clin Chim Acta.
1981;110(2-3):301-307.
77. Peters SG, Pomare EW, and Fisher CA. Portal and peripheral blood short chain fatty acid
concentrations after caecal lactulose instillation at surgery.
Gut.
1992;33(9):1249-1252.
78. Roediger WE. Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa
in man.
Gut.
1980;21(9):793-798.
79. Roediger WE. Utilization of nutrients by isolated epithelial cells of the rat colon.
Gastroenterology.
1982;83(2):424-429.
80. Fleming LL and Floch MH. Digestion and absorption of fiber carbohydrate in the colon.
Am J Gastroenterol.
1986;81(7):507-511.
81. Bornet FR, Brouns F, Tashiro Y, and Duvillier V. Nutritional aspects of short-chain fruc-
tooligosaccharides: Natural occurrence, chemistry, physiology and health implications.
Dig Liver Dis.
2002;34 Suppl 2:S111-120.
82. Hague A, Elder DJ, Hicks DJ, and Paraskeva C. Apoptosis in colorectal tumour cells:
Induction by the short chain fatty acids butyrate, propionate and acetate and by the bile
salt deoxycholate.
Int J Cancer.
1995;60(3):400-406.
83. Scheppach W, Bartram HP, and Richter F. Role of short-chain fatty acids in the preven-
tion of colorectal cancer.
Eur J Cancer.
1995;31A(7-8):1077-1080.
84. Perrin P, Cassagnau E, Burg C, Patry Y, Vavasseur F, Harb J, Le Pendu J, Douillard
JY, Galmiche JP, and Bornet F, et al. An interleukin 2/sodium butyrate combination
as immunotherapy for rat colon cancer peritoneal carcinomatosis.
Gastroenterology.
1994;107(6):1697-1708.
85. Archer SY, Meng S, Shei A, and Hodin RA. p21(WAF1) is required for butyrate-
mediated growth inhibition of human colon cancer cells.
Proc Natl Acad Sci USA.
1998;95(12):6791-6796.
86. Siavoshian S, Segain JP, Kornprobst M, Bonnet C, Cherbut C, Galmiche JP, and
Blottiere HM. Butyrate and trichostatin A effects on the proliferation/differentiation
of human intestinal epithelial cells: Induction of cyclin D3 and p21 expression.
Gut.
2000;46(4):507-514.
